Research Projects

HEPATOX-AAV


Project information

The "HEPATOX-AAV" project is carried out in the DNA and RNA Therapies division, within the Rare Diseases Targeted Therapy program, under the direction of Carmen Unzu.

 Funder: Pfizer

  • Start date: January 1, 2022
  • End date: December 31, 2024
  • Nature of project: Regional

Need more information?

If you are interested in learning more about our research, please contact us.